Nav: Home

Research on cancer-frying nanoparticles heats up

June 26, 2018

BUFFALO, N.Y. -- Need to kill tumors? Just add heat.

That's the promise of heated magnetic nanoparticles, a futuristic-sounding technology that could one day be used to fry and eradicate cancer cells without harming healthy tissue elsewhere in the body.

New research led by the University at Buffalo advances this concept, with scientists developing nanoparticles that can zap tumors with significant amounts of heat under a low magnetic field. The study was published online on June 21 in the journal Small, and was selected as a future cover article.

"The main accomplishment of our work is the greatly enhanced heating performance of nanoparticles under low-field conditions suitable for clinical applications. The best heating power we obtained is close to the theoretical limit, greatly surpassing some of the best-performing particles that other research teams have produced," says Hao Zeng, PhD, professor of physics in the UB College of Arts and Sciences, who led the project.

He explains that the therapy has a number of potential benefits over other treatment routes. It's minimally invasive, and is not expected to generate the type of severe side effects often associated with chemotherapy and radiation, he says.

"The treatment will only heat up the region where nanoparticles are without affecting healthy tissues that are further away, so we anticipate few side effects," Zeng says. "In addition, the magnetic field that's used to excite the particles can penetrate deep into the body from an instrument that does not require any contact or insertion of probes. As such, the therapy can reach parts of the body that are not easily accessible to surgery."

The study was a collaboration between UB; Capital Normal University in Beijing, China; the Chinese PLA General Hospital in Beijing; and the University of Nebraska-Omaha. Shuli He, PhD, a visiting scholar at UB from Capital Normal University, was first author.

Carefully tuned magnetic properties

A lot more research needs to be done before the nanoparticles are available to patients.

But here's how the therapy would work: First, doctors would use targeting technologies to direct nanoparticles to tumors in patients' bodies. Then, exposure to an alternating magnetic field would prompt the particles' magnetic orientation to flip back and forth hundreds of thousands of times per second. This process would cause the particles to warm up as they absorbed energy from the electromagnetic field and converted it into thermal energy in the targeted regions.

This form of cancer treatment is known as magnetic nanoparticle hyperthermia, and it's not new. But Zeng and colleagues designed new magnetic nanoparticles that get hotter and generate heat a few times faster than some of the highest-performing magnetic nanoparticles studied under low-field conditions, he says.

"Within the body, heat energy is continuously carried away -- for example, by blood flow -- making it difficult to reach the required temperature to kill cancer cells," Zeng says. "One needs particles with the highest heating power possible. Our particles have demonstrated impressive heating power even at low magnetic field amplitude and frequency deemed safe for human body."

The team crafted two types of nanoparticles, each consisting of metal alloys chosen for their ability to generate heat under a magnetic field. One of the new nanoparticles contains manganese cobalt ferrite, while the other is made from zinc ferrite.

The manganese-cobalt-ferrite particles reached maximum heating power under high magnetic fields. But the biocompatible zinc ferrite particles heated up with impressive efficiency under an ultra-low field.

"The bottom line is our zinc ferrite particles are designed for low fields suitable for clinical applications," Zeng says. "For other particles reported in the literature, the field used is typically higher. Most of these other particles are not capable of heating at our chosen field parameters."

Tested in magnetic bone cement

Zeng envisions bone cancer treatment as one early application for heated magnetic nanoparticles.

As he explains, "Typically, after a surgery to remove bone tumors, a synthetic material called bone cement is injected to fill the voids. If we introduce our nanoparticles into the bone cement, they can be heated on demand to kill any tumor cells that remain nearby, and help prevent recurrence of the cancer."

To simulate this scenario, Zeng and colleagues embedded their zinc ferrite nanoparticles into bone cement and used it to heat up a pork rib. With just a small number of nanoparticles (1 percent of the bone cement, by weight), the experimental set-up reached a temperature high enough to kill tumor cells.
-end-


University at Buffalo

Related Cancer Articles:

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.
Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.
Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.